Ascelia Pharma Announces Publication of Orviglance Clinical Study in Journal of Magnetic Resonance Imaging
Ascelia Pharma AB (publ) (STO:ACE), a biotech company focused on improving the lives of people living with rare cancer conditions, today announced the publication of a peer-reviewed article related to Orviglance® in the Journal of Magnetic Resonance Imaging (JMRI), one of the leading peer-reviewed journals in the field of magnetic resonance imaging. The article, titled "Pharmacokinetics and Pharmacodynamics of a Single Oral Dose of...
Read more







